Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial
September 24, 2024

September 24, 2024
September 18, 2024
September 16, 2024
September 11, 2024
September 6, 2024
August 27, 2024
August 21, 2024
August 20, 2024
August 20, 2024
June 8, 2026
Alithea Genomics, a pioneering biotech company specializing in scalable RNA sequencing solutions, today announced a new agreement with Revvity Inc. to...
June 1, 2026
Designed to adapt to diverse biopharma development needs, and enabled by close collaboration and parallel execution, the partnership introduces a flex...
June 1, 2026
Spectronaut 21 (DIA) and SpectroMine 6 (DDA): cloud-enabled processing, increased identifications, enhanced PTM identification and site localization c...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225